Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Decoding Digital

Decoding MEDDICC: Andy Whyte on Optimizing Revenue and Accelerating Growth

21 Mar 2023

Description

Andy Whyte has literally written the book on the power of the MEDDICC sales system. His book, “MEDDICC: The ultimate guide to staying one step ahead in the complex sale,” outlines how to apply the MEDDICC framework to any sales deal. But before Andy became a powerhouse in sales, he was an account executive at impressive companies like Oracle and Sprinklr. He also led many successful sales teams at various companies before starting out on his own. Today, Andy is the CEO and founder of MEDDICC, an organization that helps build elite competency in sales teams. In today's episode, Andy talks about how the best salespeople are good at solving their customers' problems. He shares his three critical parts to selling, how companies can best adopt and implement MEDDICC, and the big changes he's seen in sales as companies evolve from enterprise-led to product-led. Press play to hear Andy’s thoughts on…Overcoming challenges in sales"There's not often a deal where everything's green, and everything's great, right? If there ever is, you know, they get called a bluebird. There's often challenges. What we like to say is the best salespeople are the ones who are the fastest to identify what the challenges are, and they're the ones who put their hands up."Time efficiency "I'm really big on this idea of just being more efficient with your time and therefore double down on your winners. You can only double down on the winners if you have a framework that's going to help you identify who the winners are, which is bringing it all back to MEDDICC."

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.